Firstime https://www.firstime.vc/ A VC for a Better Twenties Tue, 12 Nov 2024 07:56:44 +0000 en-US hourly 1 https://wordpress.org/?v=6.7.1 https://www.firstime.vc/wp-content/uploads/2021/05/favicon-150x150.pngFirstimehttps://www.firstime.vc/ 32 32 Introducing: This Week in Climate Techhttps://www.firstime.vc/weeklynewsletter1/ Tue, 12 Nov 2024 07:46:02 +0000 https://www.firstime.vc/?p=2753📱 Introducing Our First Edition of This Week in Climate Tech 🌍 We’re excited to launch our weekly climate tech newsletter, where we will bring you fresh insights each weekend into the latest shifts and innovations. This week, Trump’s re-election initially sent ripples through renewable energy stocks, but the sector’s resilience is clear. While the MAC […]

The post Introducing: This Week in Climate Tech appeared first on Firstime.

]]>

📱 Introducing Our First Edition of This Week in Climate Tech 🌍

We’re excited to launch our weekly climate tech newsletter, where we will bring you fresh insights each weekend into the latest shifts and innovations. This week, Trump’s re-election initially sent ripples through renewable energy stocks, but the sector’s resilience is clear. While the MAC Global Solar Energy index and NextEra saw dips, the Inflation Reduction Act’s $369 billion in funding remains largely intact, backed by bipartisan support. With renewable energy costs falling and market dynamics driving growth, climate tech’s momentum is stronger than ever.

From high-stakes investments to new advancements in electric aviation and agritech, join us every week with Firstime Ventures as we track the future of climate tech.

💡 In the Spotlight

While renewable energy stocks initially tumbled on Trump’s re-election this week – MAC Global Solar Energy index dropping 10% and NextEra falling 6.2% – the sector’s underlying strength is undeterred. The Inflation Reduction Act’s $369 Billion remains largely intact with bipartisan support, as 90% of investments flow to red districts. Market dynamics, not elections, continue to drive momentum: solar and wind costs have plunged 88% and 68%, making them more affordable than ever. Evidence builds daily—TotalEnergies maintaining U.S. investment plans, Saint-Gobain securing major renewable deals, Archer landing $500M aviation contracts, and Northern-Arc launching a $65M climate fund in India. Global investors with $33T in assets demand climate action, and states like California are approving $10B in climate bonds. The green transition is accelerating on solid commercial footing, moving beyond political dependency.

⚡ Energy Transition

Archer secures potential $500M Japanese deal through JAL-Sumitomo venture for 100 electric aircraft, targeting 2025 commercial launch.

Norwegian FREYR enters US solar manufacturing by acquiring Trina’s $340M Texas facility amid growing domestic production push.

Beta Technologies raised $318M Series C funding from Fidelity, TPG, and Qatar’s QIA, advancing electric aircraft production and certification.

Mainspring Energy secures $96M to manufacture fuel-flexible Linear Generators, establishing a large-scale Pittsburgh manufacturing facility.

French ZE Energy secures €54M led by Amundi Energy Transition for European solar-storage expansion strategy.

Polish solar attracts €81M investment as Econergy and Phoenix secure a long-term deal with a global industrial buyer.

Norwegian Glint Solar receives $8M Series A backing to scale global solar development software across European markets.

Meta expands Texas solar footprint through 260MW Engie partnership, strengthening US data center renewable supplies.

Retail giant H&M partners with Lightsource bp on a 125MW Texas solar farm, expanding US corporate renewable procurement.

French industrial Saint-Gobain locks 110GWh renewable supply through 20-year Boralex partnership across three facilities.

♻ Circular Economy & Novel Materials

DOE backs Moment Energy’s $20M Texas battery recycling facility, targeting EV-to-grid storage conversion market.

🚜 Ag-Tech

Days after US elections, DFC backs Indian agritech platform Arya.ag with $19.8 million, strengthening Indo-Pacific digital agriculture investments.

Marine robotics startup Ulysses raises $2M from Lowercarbon Capital, commercializing automated seagrass restoration with government partnerships.

☁ Carbon-Tech

Canada backs Pratt & Whitney’s $34.9M advanced thermal engine research, aiming to reduce aviation emissions through improved fuel efficiency.

🌳 Other Climate News

UAE signals regional energy transition leadership with $54B commitment while maintaining position as key global energy supplier.

Global investors managing $33 trillion unite ahead of COP29, demanding stronger climate policies to accelerate private sector climate investments.

California strengthens West Coast climate leadership with $10B bond approval, advancing offshore wind and grid infrastructure development.

Days after the US elections, DFC channels $50M into Indian climate fund, maintaining American green financing commitments in Asia.

📈 Market Monitor

Our Market Monitor tracks the performance of key stocks and sector ETFs, providing weekly and year-to-date changes for market analysis and trend identification.

📝 Omer Agadi, Data Analyst, Firstime Ventures

The post Introducing: This Week in Climate Tech appeared first on Firstime.

]]>
The Indispensable Role of Carbon Removalhttps://www.firstime.vc/role-of-cdr/ Mon, 29 Jan 2024 08:32:19 +0000 https://www.firstime.vc/?p=2684 Insights by Dr. Avner Gross for Firstime Ventures, Edited by Itamar Weizman   Introduction Firstime VC is deeply invested in addressing the multifaceted challenge of climate change. A crucial aspect of this challenge is Carbon Dioxide Removal (CDR). This article explores why CDR is critical in the fight against climate change and how it […]

The post The Indispensable Role of Carbon Removal appeared first on Firstime.

]]>

Insights by Dr. Avner Gross for Firstime Ventures, Edited by Itamar Weizman

Introduction
Firstime VC is deeply invested in addressing the multifaceted challenge of climate change. A crucial aspect of this challenge is Carbon Dioxide Removal (CDR). This article explores why CDR is critical in the fight against climate change and how it complements traditional emission reduction strategies.
Understanding the Urgency of Carbon Dioxide Removal
Climate change, a formidable threat to our global ecosystem, necessitates a comprehensive strategy that extends beyond reducing emissions. The latest findings, including those from the IPCC’s 6th Assessment Report, emphasize the importance of not only limiting but also reversing the atmospheric accumulation of CO2. This reversal is where CDR technologies become indispensable.
Figure 1. Schematic illustration of NET deployment timing and scale
CDR: A Critical Component of Climate Strategy
While reducing emissions is crucial, it’s only part of the solution. CDR technologies have the unique potential to actively remove existing carbon dioxide from the atmosphere, a necessary step to meet the global warming targets set by international climate agreements. By extracting CO2 from the air, CDR can help mitigate the effects of past emissions and is a vital tool in achieving long-term climate goals.
The Diverse Landscape of CDR Technologies
The field of CDR encompasses a variety of approaches, each with unique mechanisms and potential impacts:
1. Direct Air Capture: DAC technologies involve capturing CO2 directly from the atmosphere, offering a scalable solution to actively reduce atmospheric carbon levels.
2. Enhanced Weathering: This method accelerates natural geological processes to capture and store carbon dioxide, potentially transforming large areas into carbon sinks.
3. Ocean-Based Solutions: Techniques like ocean alkalinity enhancement and carbon capture in marine environments highlight the ocean’s significant role in carbon sequestration.
4. Biological Approaches: Leveraging the natural carbon-absorbing capabilities of forests, soils, and other ecosystems, these methods focus on enhancing and preserving natural carbon sinks.
Figure 2. Various carbon removal technologies and how they capture and store CO2. The artwork was taken from Rita Erven (GEOMAR)
Challenges and Opportunities in CDR Development
The development of CDR technologies faces numerous challenges, including scalability, cost, and environmental impact. However, these challenges also present opportunities for innovation and technological advancement. Effective CDR solutions require multidisciplinary approaches and collaboration across sectors and borders.
Our dedication to supporting CDR
We believe that investing in CDR is not just an environmental imperative but also an opportunity to pave the way for sustainable technological advancements. As we continue to support cutting-edge solutions in this field, our focus remains steadfast on contributing to a healthier, more resilient planet.
Dr Avner Gross, The Department of Geography and the School of Sustainability and Climate Change, Ben Gurion University of the Negev, Israel

The post The Indispensable Role of Carbon Removal appeared first on Firstime.

]]>
Introducing Firstime Credit – Leading Financial Ingenuity in Climate Techhttps://www.firstime.vc/introducing-firstime-credit/ Tue, 16 Jan 2024 07:56:54 +0000 https://www.firstime.vc/?p=2601By: Yoni Ophir, Co-Founding Partner & CEO, Firstime Credit  Introduction  Challenging global tech market sparks our creativity and professional backgrounds to create innovative financing solutions and resources for Climate Tech ventures. I am therefore proud to introduce Firstime Credit at Firstime Ventures. We launched Firstime Credit to support Climate Tech companies through these tumultuous times, where […]

The post Introducing Firstime Credit – Leading Financial Ingenuity in Climate Tech appeared first on Firstime.

]]>

By: Yoni Ophir, Co-Founding Partner & CEO, Firstime Credit

Introduction

Challenging global tech market sparks our creativity and professional backgrounds to create innovative financing solutions and resources for Climate Tech ventures. I am therefore proud to introduce Firstime Credit at Firstime Ventures. We launched Firstime Credit to support Climate Tech companies through these tumultuous times, where Israel and the world grapple with unique challenges and confront economic challenges. The launch of Firstime Credit is more than just a financial venture; it’s a commitment to sustain innovation in climate technology. Our approach is cautious yet determined, acknowledging the need for stability and support for ventures developing sustainable technologies.

The Role of Credit in Climate Tech

Credit financing is crucial for climate tech companies, especially for those in stages requiring heavy investment in hardware and scaling operations. With my background in credit and investing, I deeply understand the intricacies of tailoring financial solutions that are effective and attuned to the current market realities.

Navigating the “Valley of Death”

The “Valley of Death” – the transition from development to revenue generation – is a critical phase for Climate Tech startups. At Firstime Credit, we aim to provide the necessary support during this pivotal stage, offering a financial lifeline to these companies.

Our Financial Solutions

We offer a range of financial products with flexible terms, designed to meet the varied capital needs of climate tech companies. This approach considers the need for infrastructure development and the scaling of operations, while being sensitive to the economic and geopolitical climate.

Apply for Firstime Credit

Introducing Firstime Credit is a step towards supporting the climate tech industry responsibly and sustainably, especially in these complex times. We aim to enable these companies to continue their crucial work in developing technologies for a sustainable future, providing them with the financial tools and support they need to navigate these challenging times.

Want to apply for credit? Apply here

—

Yoni Ophir is Co-Founding Partner & CEO of Firstime Credit. His professional experience includes roles as Executive Vice President, Head of Credit and Board Member at Altshuler Shaham, a leading $50B Israeli asset manager, Executive Vice President with Kushner Companies and Hedge Fund Manager Yoni also served as VP Investments at Origo Debt Fund, an Investment Banker at Raymond James (NYSE: RJF) in NYC, and an M&A Lawyer at Paul Weiss in NYC. Yoni has an LL.M. in law and Executive M.B.A. from NYU, and an LL.B. in law and B.A. in economics from Tel- Aviv University. Yoni is admitted to practice law in both Israel and New York State Bars.

The post Introducing Firstime Credit – Leading Financial Ingenuity in Climate Tech appeared first on Firstime.

]]>
2024: A Turning Point for Mental Healthhttps://www.firstime.vc/talkspace2024/ Tue, 09 Jan 2024 08:07:21 +0000 https://www.firstime.vc/?p=2463By: Keren Kopilov, Partner & Head of Digital Health. Firstime Ventures has been invesing in digital health and mental health since 2014. Looking for funding for your innovative mental health solution? Apply Here Talkspace’s Role and Industry Insights As we step into this year with high hopes and new initiatives at Talkspace, our portfolio company, […]

The post 2024: A Turning Point for Mental Health appeared first on Firstime.

]]>
By: Keren Kopilov, Partner & Head of Digital Health.
Firstime Ventures has been invesing in digital health and mental health since 2014. Looking for funding for your innovative mental health solution? Apply Here

Talkspace’s Role and Industry Insights

As we step into this year with high hopes and new initiatives at Talkspace, our portfolio company, we wanted to take a moment to reflect on the broader landscape of mental health in the U.S., particularly in light of our recent endeavors and evolving industry trends.

Since 2020, with the breakout of COVID-19, there has been an undeniable acceleration of the need for mental health care. Historically sidelined, mental health has now become a focal point of global health priorities. The pandemic triggered a 25% increase in anxiety and depression worldwide, particularly affecting young people, women, and those with pre-existing conditions.

Talkspace’s Initiatives

In embracing this challenge, Talkspace launched the ‘Go Head First Into 2024’ campaign, moving beyond traditional resolutions to prioritize mental well-being. Additionally, our participation in the Nasdaq Stock Market Closing Bell ceremony on January 3, 2024, symbolized our commitment to this cause.

Industry Challenges and Solutions

The U.S. mental health sector, however, faces several challenges, including a surge in mental health issues, accessibility, affordability, insurance complexities, and a shortage of qualified professionals. For instance, 21% of adults experience mental illness, yet 55% receive no treatment, often due to high costs or lack of insurance.

To address these issues, integrated care and expanding the workforce are crucial. The Biden administration’s proposed $700M investment in 2022 to expand the mental health workforce is a step in the right direction. Moreover, increasing reimbursement rates can encourage more professionals to join insurance networks.

2024 US Budget

In President Biden’s FY 2024 budget, a significant focus is placed on mental health, with several key investments earmarked to address the crisis. The budget includes a $2 billion allocation for the Mental Health System Transformation Fund to expand services and workforce development. Additionally, $387 million is proposed for training behavioral health providers, a $190 million increase from the previous year. The SAMHSA Minority Fellowship Program is set to receive $37 million, reflecting a $17 million increase. Furthermore, $836 million is allocated for the 988 and Behavioral Health Services program, marking a $334 million rise from FY 2023. These figures represent a substantial commitment from the Biden administration towards enhancing mental health care and services in the United States

The Role of Technology

Telehealth has been a game-changer, accounting for 36% of mental health visits in 2021. This technology needs further expansion to meet the growing demand. At Talkspace, we understand the importance of technology in democratizing access to mental healthcare.

Market Trends

The rapid growth in primary care platforms and the adoption of hybrid models combining telehealth with traditional services are reshaping the landscape. There’s also a shift toward B2B virtual care solutions.

Investment Insights

Despite a challenging year for digital health funding in 2023, investment in behavioral health remained strong. Companies like Author Health and Spring Health are leading the way with significant funding rounds, indicating a robust interest in mental health startups.

Public Mental Health Companies

Talkspace, going public in 2021 with a $1.4B SPAC merger, is focusing on B2B efforts and projects profitability by the end of the year. Other companies like Teladoc and LifeStance are also key players in this sector.

The mental health crisis in America is a call to action for us all. The evolving telehealth market, estimated at $200B, offers solutions to many challenges. As part of this industry, Talkspace is committed to contributing positively to this landscape, leveraging technology and innovative care models to enhance mental health access and treatment.

As we continue through 2024, we’re going to keep an eye on this encouraging development where mental health care, technology, and investment interests converge, paving the way for a healthier, more mindful society.f

The post 2024: A Turning Point for Mental Health appeared first on Firstime.

]]>
BeeHero raises $42 million Series Bhttps://www.firstime.vc/beeheroseriesb/ Sun, 11 Dec 2022 09:56:00 +0000 https://www.firstime.vc/?p=2422BeeHero raises $42 million Series B for precision pollination platform BeeHero, which has developed a precision pollination platform, announced on December 2022 that it has completed a $42 million Series B funding round. Lead investor Convent Capital was joined by General Mills, Cibus Capital, Rabobank, Firstime, MS&AD, J-Ventures, Plug&Play, iAngels, Gaingels, UpWest, and more. To date, BeeHero […]

The post BeeHero raises $42 million Series B appeared first on Firstime.

]]>

BeeHero raises $42 million Series B for precision pollination platform

BeeHero, which has developed a precision pollination platform, announced on December 2022 that it has completed a $42 million Series B funding round. Lead investor Convent Capital was joined by General Mills, Cibus Capital, Rabobank, FirstimeMS&AD, J-Ventures, Plug&Play, iAngels, Gaingels, UpWest, and more. To date, BeeHero has raised $64 million. This new round of funding will enable BeeHero to further invest in R&D and help generate more data and insight into the sustainable agriculture ecosystem it is building to address the issue of global food security.

BeeHero CEO, Omer Davidi:

“The investment from General Mills is a massive achievement for us. Agriculture is very important to them and they identified the pollination problem long ago and that there are ways to address it. They are a strategic investor that will open doors for us going forward. The recession has meant that clients are trying to be more efficient and our solution helps them do that.”

What does BeeHero do?

BeeHero brings a technological revolution to the traditional field of agriculture and pollination management. The company represents a strong and capable team with a wide background in the pollination technology field, has achieved significant growth in the last 24 months and won the trust of major clients.  With a first-mover advantage and cutting-edge technology that is relevant for a wide range of crops, BeeHero is well placed to lead the growing pollination market globally.

A brief history of BeeHero

Itai Kanot grew up among his father’s farm, who is also the largest private beekeeper in the country. From a young age, he knew that his future was among the bees. As a young adult, he met high-tech expert Omar Davidi, and the two of them collaborated to find a solution to the world’s declining bee population. 

Starting in 2017, with 10 hives in the backyard in Israel, their firm BeeHero now keeps track of 120,000 hives throughout the US, and has over 55 employees headquartered in the US and R&D centers and research labs in Israel and Italy.

Why did we invest in BeeHero?

BeeHero brings a technological revolution to the traditional field of agriculture and pollination management. The company represents a strong and capable team with a wide background in the pollination technology field, has achieved significant growth in the last 24 months and won the trust of major clients.  With a first-mover advantage and cutting-edge technology that is relevant for a wide range of crops, BeeHero is well placed to lead the growing pollination market globally.

The post BeeHero raises $42 million Series B appeared first on Firstime.

]]>
Why did Firstime invest in Hygieiahttps://www.firstime.vc/whyhygieia/ Sat, 18 Jun 2022 04:32:51 +0000 https://www.firstime.vc/?p=2370A brief history of Hygieia  Taking insulin is a very mundane task for patients with diabetes, one of the most common chronic diseases in the world. Most people need 1 to 4 injections per day for blood sugar regulation. The insulin dosage is adjusted by doctors after considering the daily changes in the patient’s body. […]

The post Why did Firstime invest in Hygieia appeared first on Firstime.

]]>

A brief history of Hygieia 

Taking insulin is a very mundane task for patients with diabetes, one of the most common chronic diseases in the world. Most people need 1 to 4 injections per day for blood sugar regulation. The insulin dosage is adjusted by doctors after considering the daily changes in the patient’s body. In addition, treating the disease is expensive. According to the American Diabetes Association, “people with diagnosed diabetes account for more than 1 in 5 health care dollars in the U.S.”

With the stakes so high, in 2008, Eran Bashan and Israel Hodish, two researchers at the University of Michigan, founded Hygieia and developed d-Nav to make insulin therapy safer and more effective without increasing the burden on the healthcare system.

The d-Nav program, with FDA-cleared technology, has been thoroughly tested, reviewed, and patented internationally over the last decade. The company expanded its clinical treatment from Northern Ireland in 2013 to the US at the beginning of 2019. 

To date, the company has 20 employees, has generated a total of $13M in revenues, and raised ~$17M in funding from various family offices, the Blue Cross Blue Shield of Michigan (BCBSM), Conductive Technologies, and Oakwood Medical Investors. 

Addressing the elephant in the room: Insulin mismanagement and inefficiency 

Globally, type 2 diabetes affects more than 450 million people. More than 30 million people in the US have type 2 diabetes. More than 7 million Americans with type 2 diabetes use insulin, and more than $14 billion is spent on insulin annually in the US. Yet nearly two-thirds of the patients don’t get successful results and experience disease-related symptoms. 

This poses a major problem in a massive subsector of pharma – insulin mismanagement. In monetary terms, over $175 billion in healthcare expenses arise due to health complications that are caused by insulin mismanagement amongst Americans with type 2 diabetes. 

A single patient needs 50-100 dosage adjustments a year for effective insulin treatment. Primary care physicians are responsible for these adjustments, but they often lack the time or expertise to accommodate this process of insulin treatment. Most patients only visit their doctor maybe 2 or 3 times a year. It is no wonder that the problem here is not drug efficacy but rather drug administration. This is where Hygieia intends to fill this gap.   

Enter Hygieia: A patented and FDA-approved insulin management program

The US-based start-up Hygieia is looking to improve the lives of millions of people with type 2 diabetes in the US, the UK, and the EU so far. Its revolutionary D-NavÂź insulin management program is an FDA-approved program that transforms insulin management through a mobile app that guides patients to optimize insulin doses at home based on their changing glucose levels. With the use of patented technology, artificial intelligence, and virtual clinical support to automate insulin titration based on each patient’s unique needs. 

        

To use the d-Nav program, patients insert their glucose test strips into the handheld device. The patient’s information is uploaded to the cloud to be analyzed. Artificial intelligence and a proprietary algorithm are applied to make an insulin dose recommendation, based on the current reading and patient historical data, for each injection throughout the day and week.

The great thing is that the program is covered by most insurance carriers, as well as Medicare and Medicaid, allowing physicians to refer cases with confidence. That means Hygieia profits from the savings healthcare providers achieve as a result of this program, rather than directly charging the end-users (the patients). This is a proven win-win-win; patients feel better, insurance and healthcare providers save money, and Hygieia fills the gap. 


Why did we invest in Hygieia?

The global digital diabetes management market is predicted to grow at an annual rate of almost 20 percent, reaching a size of $27 billion in 2026. As mentioned before, 450 million people suffer from type 2 diabetes. Again, over 7 million Americans, or in other words, one-fifth of type 2 diabetes patients, could benefit from Hygieia’s solution in the United States. Therefore, Hygieia can potentially serve a fourth of the 450 million people globally – i.e., 100+ mil – in a market that will double every four years. 

Furthermore, Hygieia’s business model is not just a theory – it has strong proof of concept and scalability. So far, over 4 million doses have been prescribed by Hygieia’s program. That’s no small feat, especially considering the regulatory difficulties of this space. The D-NavÂź program has FDA approval and is CE marked, with over 100 global patents securing the technology that makes this solution possible. We believe Hygieia has the traction and the first mover advantage to keep leading this breakthrough.

The post Why did Firstime invest in Hygieia appeared first on Firstime.

]]>
Maverick Medical closes $5 million seed roundhttps://www.firstime.vc/maverickseedround/ Thu, 10 Mar 2022 14:24:54 +0000 https://www.firstime.vc/?p=2320Maverick developed an AI platform, mCoder, that addresses the challenges of medical coding efficiency, accuracy, and capacity  The round was led by venture capital funds Lionbird and Firstime Ventures, together with entrepreneur investors Ariel Maislos, Ofir Shalvi, Ehud Weinstein and Eli Ben Dor. The company previously raised a total of $2 million in pre-seed investment.  […]

The post Maverick Medical closes $5 million seed round appeared first on Firstime.

]]>

Maverick developed an AI platform, mCoder, that addresses the challenges of medical coding efficiency, accuracy, and capacity

The round was led by venture capital funds Lionbird and Firstime Ventures, together with entrepreneur investors Ariel Maislos, Ofir Shalvi, Ehud Weinstein and Eli Ben Dor. The company previously raised a total of $2 million in pre-seed investment.

Founded in 2018 by Yossi Shahak and Michael Brozino, Maverick has developed an AI platform, mCoder, that addresses the medical coding efficiency, accuracy, and capacity challenges impacting the healthcare revenue cycle by providing a single SaaS platform for healthcare providers across all care settings. Maverick’s platform addresses multiple clinical specialties to enable standardized coding.

Maverick’s platform has been validated and used by several leading U.S. healthcare providers in the $16.4 billion U.S. medical coding market (2020 figures).

Read the full article on C Tech

The post Maverick Medical closes $5 million seed round appeared first on Firstime.

]]>
Why did Firstime invest in BeeHerohttps://www.firstime.vc/whybeehero/ Tue, 18 Jan 2022 04:06:15 +0000 https://www.firstime.vc/?p=2346TL;DR:  BeeHero brings a technological revolution to the traditional field of agriculture and pollination management. The company represents a strong and capable team with a wide background in the pollination technology field, has achieved significant growth in the last 24 months and won the trust of major clients.  With a first-mover advantage and cutting-edge technology […]

The post Why did Firstime invest in BeeHero appeared first on Firstime.

]]>

TL;DR:

BeeHero brings a technological revolution to the traditional field of agriculture and pollination management. The company represents a strong and capable team with a wide background in the pollination technology field, has achieved significant growth in the last 24 months and won the trust of major clients.  With a first-mover advantage and cutting-edge technology that is relevant for a wide range of crops, BeeHero is well placed to lead the growing pollination market globally.

A brief history of BeeHero

Itai Kanot grew up among his father’s farm, who is also the largest private beekeeper in the country. From a young age, he knew that his future was among the bees. As a young adult, he met high-tech expert Omar Davidi, and the two of them collaborated to find a solution to the world’s declining bee population.

Starting in 2017, with 10 hives in the backyard in Israel, their firm BeeHero now keeps track of 100,000 hives throughout the US, and has 20 employees headquartered in the US and R&D centers and research labs in Israel and Italy.

How to feed nine billion people? Bees.

A new crisis looms on the horizon. By the year 2050, nine billion people will inhabit planet earth. Feeding them sustainably and nutritiously will be one of the most wicked challenges facing humanity.

Achieving global nutritional security over the next 30 years will require agricultural production to increase by 60 per cent. This increase in production will be driven by insect-pollinated crops that have increased by over 300 per cent in the last 50 years.

About three-quarters of the world’s food crops rely on insect pollination (mainly bees). Particularly, bee pollination plays a crucial role in food production – increasing yield and quality, nutritional value, shelf life, and commercial value. Yet nearly 40 per cent of bee colonies collapse every single year.

The pollination deficit

The term “pollination crisis” highlights the global decline in pollinator abundance and diversity in large parts of the world that will critically impact the human food supply chains.

This impending emergency was also noted in the European Parliament’s resolution that stated: ‘
only bees, in sufficient numbers, can guarantee pollination
it is essential to respond without delay to the crisis in bee health in an appropriate manner with effective weapons’.

The health and effectiveness of the beehives depend on the number, spread, and strength of colonies and the timing of their introduction. However, currently, there are no data management tools or systems for farmers to base their pollination management decisions.

Enter BeeHero: A data-driven yield-enhancing technology

Founded in 2017, BeeHero is a California-based start-up aiming to optimize the way we pollinate our crops. Harnessing the power of the internet of things and machine learning, BeeHero’s platform monitors beehive activity. The breakthrough development integrates beehive data with other relevant environmental, horticultural, and agronomic data, advanced analytical modeling, and visualization techniques that, for the first time, enable the direct measurement and optimization of bee pollination input for food production.

Simply put, there are three phases to the technology that is BeeHero.

  1. IoT sensors are placed in beehives in order to collect data about the bee environment and activity at scale. The collected data is then integrated with other external environmental and agronomic datasets including factors ranging from weather to soil quality.
  2. Advanced analytical methods, such as machine learning and artificial intelligence, are then used to transform the data into actionable insights for pollination management.
  3. These insights are visible to farmers on a user-friendly platform, providing key metrics to support management decisions with regard to pollination. It doesn’t stop there, however. In fact, BeeHero also facilitates these pollination services by partnering up with beekeepers nationwide.

Data & Main Deliverables

BeeHero delivers precision pollination services that optimize crop yield and minimize overhead.

  1. Strong pollination resources: that automatically monitor and report the colony health and actionable data year-round, to the farmers.
  2. Optimal Pollination Inputs: BeeHero’s algorithms provide accurate bee frame counts to quantify the number of bees delivered per acre of crop. And provides necessary hive status that reduces farmers’ exposure to risks from unknown hive numbers and strengths.
  3. Maximized Pollination Efficacy: Data-driven best practices for different crops, varieties, locations, and field sizes that optimize crop yield and quality ensure maximum crop yields.

The current success has given BeeHero the motivation to explore new applications of its technology. This includes solutions that range from the financial support of beehive leasing and the customization of insurance models all the way to creating the largest bee and pollination database that predicts different agricultural uncertainties.

Why did we invest in BeeHero?

BeeHero brings a technological revolution to the traditional field of agriculture and pollination management. The company represents a strong and capable team with a wide background in the pollination technology field, has achieved significant growth in the last 24 months and won the trust of major clients.  With a first-mover advantage and cutting-edge technology that is relevant for a wide range of crops, BeeHero is well placed to lead the growing pollination market globally.

The post Why did Firstime invest in BeeHero appeared first on Firstime.

]]>
🌍  2021 was the year of climate action 🌍https://www.firstime.vc/2021-was-the-year-of-climate-action/ Wed, 29 Dec 2021 09:55:27 +0000 https://www.firstime.vc/?p=2263During the past year, we have seen more and more governments, institutions, firms, and investors realize that the climate crisis requires serious action. We achieved a record number of sustainable investments, unprecedented climate action, a massive deployment of renewable energy, a variety of cutting-edge innovations, and the launch of Firstime 3: our climate-tech fund. There’s no […]

The post 🌍  2021 was the year of climate action 🌍 appeared first on Firstime.

]]>

During the past year, we have seen more and more governments, institutions, firms, and investors realize that the climate crisis requires serious action.

We achieved a record number of sustainable investments, unprecedented climate action, a massive deployment of renewable energy, a variety of cutting-edge innovations, and the launch of Firstime 3: our climate-tech fund.

There’s no better way of celebrating the new year than by reminding ourselves of all the great things that happened this past year.

As we are entering the new year – here are our 21 reasons to be cheerful for 2021:

💰 Investors poured $2.2b into Israeli climate tech companies in 2021, turning climate-tech into one of the fastest-growing markets.

🩄 15 climate tech startups reached Unicorn status this year, reaching a total of 31 unicorns. BlackRock CEO Larry Fink recently said that he believes “the next 1,000 unicorns will be in climate tech”.

⚡ 2022 will be a record year for wind and solar, a new report finds, and this is just the beginning of the renewable energy revolution!

🚗 2021 was a massive year for electric cars. 2022 will be even bigger. Electrification of our transportation is key to reducing our CO2 emissions.

🙌 Firstime (that’s us!) announces $100 million climate-tech fund, backed by Jonathan Kolber. Our new fund has already made 2 inaugural investments and we are planning to announce 3 more investments in the coming quarter.

💹 US and EU announced a global pledge to slash methane, during COP26 in Glasgow. Methane is 84x more potent than CO2 and contributes to 25% of global warming.

đŸ‡ȘđŸ‡ș The European Union pledged to become the world’s first climate-neutral continent by 2050! The EU pledged to reduce emissions by 55% by 2030. This will create new opportunities for innovation and investment and jobs

đŸ©ș Telehealth use has increased 38X from the pre-COVID-19 baseline, as COVID-19 showed how telemedicine could change how we think about care interactions

🐝 Firstime Ventures participated in BeeHero’s $15M investment round, as it continues to grow and become a global leader in pollination technology.

⚡ World’s biggest offshore wind farm is now online. The wind farm will use 165 turbines with a capacity of more than 1.3 gigawatts, powering over a million homes when finished.

đŸ‡źđŸ‡± Prime Minister Naftali Bennett aims to make Israel a climate-tech leader. At the COP26 in Glasgow, Bennett pledged to mobilize Israel’s startup ecosystem to fight climate change.

💉 Firstime Ventures led Hygieia’s $17 million Series B investment round, after receiving an FDA approval for their live-saving insulin management solution.

🇩đŸ‡Ș UAE-Israel relations are closer than ever. 2022 will be the time to build on them and strengthen our regional ties around shared climate concerns.

đŸ‡źđŸ‡± Israel’s UBQ Materials has raised $170M, for developing plastic-like material made from 100% unsorted household waste.

đŸ„© The cultured meat revolution is coming out of Israel: Aleph Farm has raised $105M, helping to reduce greenhouse gas emissions from the meat industry.

đŸ„ Investments in Israeli digital health companies cross the $1B mark for the first time, as Startup Nation Central revealed in a report.

đŸ‡źđŸ‡± Israel’s financial services regulator required companies to factor in ESG. We are catching up with the global investment trend on environmental, social, and governance risks.

🌎 Report reveals internet searches for sustainable goods increased dramatically, as consumers are concerned with the impact of their choices on the global climate crisis.

đŸŒČ A global pledge to halt deforestation: 2021 was a game-changing year for trees as 100 global leaders vowed to end deforestation by 2030.

🏩 450 banks & funds have joined Alliance for Net-Zero. During COP26 in Glasgow, the managers of 40% of the world’s total investable assets have signed up to 2050 net-zero goals.

đŸ‡źđŸ‡± Israeli ag-tech startup Prospera acquired by Valmont for $300 million, marking a successful acquisition in Israel’s growing Climate-tech market.

The post 🌍  2021 was the year of climate action 🌍 appeared first on Firstime.

]]>
100 years to the discovery of insulin: Why we invest in Diabeteshttps://www.firstime.vc/100yearsinsulin/ Mon, 13 Dec 2021 14:55:45 +0000 https://www.firstime.vc/?p=2243Keren Kopilov, Firstime Partner & Head of Digital Health, writes about her personal experience with Diabetes: A decade has passed since Monday, November 21, 2011. Every minute of that day is engraved in my memory as if it occurred only yesterday. I remember myself in an Intensive Care Ambulance, my daughter, then only two years […]

The post 100 years to the discovery of insulin: Why we invest in Diabetes appeared first on Firstime.

]]>

Keren Kopilov, Firstime Partner & Head of Digital Health, writes about her personal experience with Diabetes:

A decade has passed since Monday, November 21, 2011. Every minute of that day is engraved in my memory as if it occurred only yesterday.

I remember myself in an Intensive Care Ambulance, my daughter, then only two years old, connected to a myriad of IV lines and being transported to the hospital with a suspected diagnosis of Type 1 Diabetes.

During the two weeks leading up to that day, I noticed a radically increasing thirst and agitation. Those around us attributed the agitation to the challenges of the “terrible two” and were not particularly concerned regarding her unquenchable thirst: “let her drink water, the more, the better, it is healthy.” The doctors that made a nighttime house call and the other physician, a pediatrician in the pediatric emergency room, did not express much concern regarding the symptoms and attributed the heavy breathing to pneumonia and dyspnea.

My maternal instincts refused to allow me to give up. To me, everything seemed different. Abnormal. I returned to our family physician and demanded that she check blood sugar levels. These instincts saved my daughter.

This journey began during two long nights in the pediatric ICU, continued learning a previously unknown language, and was characterized by complex challenges that vary with age and life phases.

Annually during the month designated as Diabetes Awareness Month, giant headlines in the press all display concerning data: The numbers continue to climb and are expected to grow to approximately 650 million patients in 2030. One in five people over the age of 65 already have diabetes. Some 27 years ago, diabetes was declared a pandemic, and since then, the number of patients has only continued climbing.

Some 6.7 million people died over the last year from diabetes, more than those who died from the Coronavirus.

Diabetes occurs when the pancreas is no longer capable of producing more insulin or when the body cannot optimally utilize its insulin.

Insulin, a hormone manufactured by the pancreas, is the “key” that enables the sugar created from the dissolution of the carbohydrates that we eat to pass from the bloodstream into our cells to create energy.

The inability to produce insulin or to use it efficiently leads to an increased blood sugar level that in the long-term causes harm and various organ and tissue failures. Diabetes is a 24/7 job.

The patients do not get a moment’s rest from this illness and are obligated to maintain a strict, healthy diet and engage in sports.

People with diabetes must constantly monitor their blood sugar levels. Those who inject insulin must count carbohydrates and calculate the quantities of insulin that they need to inject throughout the day when an overdose of insulin is liable to cause a possibly lethal condition of low blood sugar known as hypoglycemia, and the insufficient injection of insulation – can lead to high blood sugar levels, otherwise known as hyperglycemia, and severe, long-term health implications.

The “job” is exhausting and tiring and poses a heavy burden on diabetics’ shoulders.

Over the years, technologies have been developed to improve the lives of those living with diabetes, such as continuous blood glucose meters and insulin pumps, used primarily by Type 1 Diabetes patients. The “artificial pancreas” technology, for example, enables a closed cycle of sugar monitoring and insulin injections according to the sugar levels that improve the balance at a substantial level and, more than that saves lives.

An important and extraordinary biotechnological breakthrough has been achieved recently by the Vertex Co. that two earlier acquired Semma, a company established by Professor Doug Melton, a father to two children with Type 1 Diabetes. A single patient received an IV of insulin-producing stem cells as part of the clinical trial. After 90 days, a substantial balance in blood sugar levels was indicated while reducing insulin consumption by more than 90%(!). This significant achievement brings good news to the millions of people with diabetes with Type 1 Diabetes. By the year’s end, the ViaCyte Co. will also initiate an additional clinical trial in defending stem cells converted to insulin-secreting beta cells through a shield that protects against the immune system, which in contrast to the Vertex experiment does not require immune system suppression. These two companies received support from the international JDRF that seeks a cure for Type 1 Diabetes.

Until such a cure is found, there is tremendous significance to reducing the disease’s management burden and improving diabetics’ quality of life. A unique solution facilitating the treatment burden is the DNAV application developed by Hygieia, which operates in the United States and is soon adopted in Israeli HMOs. Through algorithms that received approval of the American Federal Food and Drug Authority, the FDA, Hygieia decides instead of the diabetic and his/her physician, according to its blood sugar levels, the number of insulin units the patient must inject at any given moment and bring to a rapid and consistent balance in blood sugar levels.

Firstime Ventures recently completed a significant investment round in Hygieia, based on a profound acquaintance of the daily diabetes management burden and the desire to reduce that burden from the patients’ shoulders without compromising on balanced blood sugar levels.

The unique solution is the direct treatment in the diabetic, in contrast to other existing, excellent platforms on the market that deal in the behavioral management of chronic illnesses or offer advice regarding nutrition and a healthy lifestyle. An example of an Israeli digital company for accompanying diabetes and nutrition-based illnesses is Refeed that was established due to an entrepreneur’s personal need for precise nutritional recommendations while coping with gestational diabetes. The company that conducts pilots and clinical research with health organizations in Israel offers mentoring to people with diabetes through their personally adapted and precise nutritional plans and receives professional feedback throughout the journey. Presently, there is no solution for precise nutritional monitoring that does not involve handwritten records of meals.

An interesting Israeli company – MakeSense – is developing an artificial intelligence-based solution to precisely measure the carbohydrates and calories of each meal through a continuous glucose gauge and without the need for handwritten records.

This year Diabetes Awareness Month commemorates the century that has passed in the discovery of insulin, during which the illness was considered a death sentence for patients. Since then, the long way mankind has come clarifies the importance and significance of medical and technological innovations in the field.

The Juvenile Diabetes Research Foundation’s goals are based on the organization’s support for research to find a cure and improve the quality of life for Type 1 diabetics. While the number of technologies that gather information, monitor, and offer advice and treatment programs for proper nutrition and a healthy lifestyle continues to develop, there is still no technology that fully cancels self-treatment tasks necessary for treating diabetes.

Keren Kopilov is a partner and head of digital health at Firstime Ventures and is the  Chairwoman of the Juvenile Diabetes Research Foundation (Type 1) – JDRF in Israel.

The post 100 years to the discovery of insulin: Why we invest in Diabetes appeared first on Firstime.

]]>